AIM Rule 26
AIM Rule 26
The information below is disclosed in accordance with Rule 26 of the AIM Rules for Companies and was last updated on 18 June 2024.
Business Description
AOTI is a medical technology group with a mission to help all people with chronic conditions get back to living their lives to the fullest. Based in Oceanside, California, the Group is focused on the durable healing of wounds and prevention of amputations that are caused by various chronic wound conditions. The Group has developed an innovative, at-home therapy to deliver oxygen topically into chronic wounds, which includes diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), as well as pressure ulcers (PUs) and to encourage high-quality, durable wound healing over a period of 12 months and longer.
Board of Directors
Please click here for names and brief biographical details of each of the Directors.
Annual and Interim Reports
Please click on this link to access the Company’s Financial Reports & Publications.
Corporate Governance
Please click here for information on our Corporate Governance arrangements.
Country of Incorporation and Main Country of Operation
The Company is incorporated in the US State of Florida. Its main country of operation is the US, and it has operations in the UK and Ireland.
Rights of Shareholders
The Company is incorporated under the laws of the State of Florida, US. Accordingly, a significant amount of the legislation in England and Wales regulating the operation of companies does not apply to the Company. In addition, the laws of the State of Florida will apply in respect to the Company and these laws may provide for mechanisms and procedures that would not otherwise apply to companies incorporated in England and Wales. The rights of Shareholders are governed by Florida law and by the Articles of Incorporation and Bylaws, which may differ from the typical rights of Shareholders in the UK and other jurisdictions. It should be noted that certain provisions have been incorporated into the Articles of Incorporation and Bylaws to enshrine rights that are not conferred by the provisions of Florida Corporation Law, but which the Company believes Shareholders would expect to see in a company whose shares are admitted to trading on AIM, however there is no assurance that the courts of the State of Florida, US will uphold or allow the enforcement of these provisions.
UK Takeover Code
The Company is incorporated in the US State of Florida, and for purposes of the Takeover Panel, the Company is not resident in the UK, Channel Islands or the Isle of Man. As a result, although the Common Shares will be admitted to trading on AIM, the Company is not subject to the provisions of the City Code. However, the Company has inserted certain provisions into the Certificate of Incorporation which adopt similar procedures to the UK Takeover Code in respect of Rule 9 but there is no assurance that the courts of the State of Florida will uphold or allow the enforcement of these provisions.
Current Constitutional Documents
Please click on this link for access to our Financial Reports & Publications, including the Company’s Articles of Association.
Details of any other exchanges or trading platforms
The Company’s shares are not traded on any other stock exchange.
As described in the Company’s AIM Admission Document the requirements of the AIM Rules for Companies provide that the Company must have a facility for the electronic settlement of its Common Shares. As the Company is incorporated in the United States its Common Shares are not eligible to be held directly through CREST and, accordingly, the Company has established a Depositary Interest arrangement. The Depositary Interests representing the underlying Common Shares can be settled electronically through and held in CREST. The Depositary Interests are themselves independent securities constituted under English law and can be traded and settled within the CREST system in the same way as any other CREST security.
Shareholders that are non-US Persons have the choice of whether to hold their Common Shares in certificated form or in uncertificated form in the form of Depositary Interests within the CREST system. The Depositary Interests can be held in an ISA or SIPP.
Number of AIM securities in issue
The Company does not hold any Common Shares in treasury and therefore the number of Common Shares with voting rights is 106,359,163 as of 18 June 2024.
Number of AIM securities not in public hands
The percentage of AIM securities not in public hands is 75.0%
Significant Shareholders
Please click here to see percentage holdings of significant shareholders as notified to the Company.
Details of any restrictions on the transfer of AIM securities
The Common Stock is restricted under Regulation S Category 3 and therefore purchasers cannot sell or otherwise transfer such Common Stock except pursuant to the requirements of Regulation S until at least the expiry of one year after the date of admission.
Regulatory Notifications
Please click Regulatory News on the link to access notifications made by the Company.
AIM Admission Document and Circulars
Please click Financial Reports & Publications to access the Company’s most recent admission document.
Directors’ Responsibilities
Please click here for details of responsibilities of the members of the Board of Directors and the subcommittees of the Board.
Advisors
Please click Contacts & Advisors for details of the Company’s Nominated Adviser and other key advisers.